Theravance Biopharma, Inc. |
Director |
Ordinary Shares |
47.4K |
$410K |
$8.64 |
May 8, 2024 |
Direct |
Mereo BioPharma Group plc |
Director |
Share Options (right to buy) |
30K |
$30.3K |
$1.01 |
Aug 22, 2024 |
Direct |
Karyopharm Therapeutics Inc. |
Director |
Common Stock |
0 |
$0 |
$0.95 |
Jun 7, 2024 |
Indirect |
Mereo BioPharma Group plc |
Director |
American Depositary Shares representing Ordinary Shares |
0 |
$0 |
$4.43 |
Aug 22, 2024 |
Direct |
Karyopharm Therapeutics Inc. |
Director |
Nonstatutory Stock Option (right to buy) |
69K |
|
|
May 29, 2024 |
Direct |
PARDES BIOSCIENCES, INC. |
Director |
Class A Common Stock |
30K |
|
|
Dec 23, 2021 |
Direct |
Theravance Biopharma, Inc. |
Director |
Share Option (Right to Buy) |
23.6K |
|
|
May 8, 2024 |
Direct |
Calithera Biosciences, Inc. |
Director |
Common Stock |
0 |
|
$0.39 |
Jan 27, 2023 |
Delphi BioInvestments VIII, L.P. |
Calithera Biosciences, Inc. |
Director |
Common Stock |
0 |
|
$0.39 |
Jan 27, 2023 |
Delphi Ventures VIII, L.P. |
PARDES BIOSCIENCES, INC. |
Director |
Class B Common Stock |
0 |
|
|
Dec 23, 2021 |
Direct |